RELA and hepatocellular carcinoma: To evaluate the effect of p-p65, HCC cell lines, including LO2, HepG2, HepG2.2.15 and Hep3B cells, were treated with Bay 11-7082 (an inhibitor of IκB) (Fig. 4a).